10% Owner Of Astrana Health Sold $10.55M In Stock
Benzinga (Thu, 23-Jan 10:03 AM ET)
Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares
PRNewswire (Tue, 21-Jan 7:45 AM ET)
Astrana Health, Inc. to Participate in Upcoming Investor Conference
PRNewswire (Thu, 19-Dec 4:16 PM ET)
PRNewswire (Thu, 21-Nov 8:00 AM ET)
PRNewswire (Fri, 8-Nov 8:05 AM ET)
Astrana Health, Inc. Reports Third Quarter 2024 Results
PRNewswire (Thu, 7-Nov 4:36 PM ET)
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Astrana Health trades on the NASDAQ stock market under the symbol ASTH.
As of January 28, 2025, ASTH stock price climbed to $38.10 with 28,002 million shares trading.
ASTH has a beta of 1.32, meaning it tends to be more sensitive to market movements. ASTH has a correlation of 0.12 to the broad based SPY ETF.
ASTH has a market cap of $1.74 billion. This is considered a Small Cap stock.
Last quarter Astrana Health reported $479 million in Revenue and $.33 earnings per share. This beat revenue expectation by $16 million and exceeded earnings estimates by $.01.
The top ETF exchange traded funds that ASTH belongs to (by Net Assets): IJR, IWM, VTI, VB, VXF.
ASTH support price is $36.49 and resistance is $38.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASTH shares will trade within this expected range on the day.